<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Jpn J Cancer Res</journal-id><journal-id journal-id-type="iso-abbrev">Jpn. J. Cancer Res</journal-id><journal-id journal-id-type="doi">10.1111/(ISSN)1349-7006a</journal-id><journal-id journal-id-type="publisher-id">CAS</journal-id><journal-title-group><journal-title>Japanese Journal of Cancer Research : Gann</journal-title></journal-title-group><issn pub-type="ppub">0910-5050</issn><issn pub-type="epub">1876-4673</issn><publisher><publisher-name>Blackwell Publishing Ltd</publisher-name><publisher-loc>Oxford, UK</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">7829401</article-id><article-id pub-id-type="pmc">5919378</article-id><article-id pub-id-type="doi">10.1111/j.1349-7006.1994.tb02921.x</article-id><article-id pub-id-type="publisher-id">CAE1151</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>A Randomized Cross&#x02010;over Study of High&#x02010;dose Metoclopramide plus Dexamethasone versus Granisetron plus Dexamethasone in Patients Receiving Chemotherapy with High&#x02010;dose Cisplatin</article-title></title-group><contrib-group><contrib id="cr1" contrib-type="author" corresp="yes"><name><surname>Ohmatsu</surname><given-names>Hironobu</given-names></name><xref ref-type="aff" rid="a1"><sup>1</sup></xref></contrib><contrib id="cr2" contrib-type="author"><name><surname>Eguchi</surname><given-names>Kenji</given-names></name><xref ref-type="aff" rid="a1"><sup>1</sup></xref></contrib><contrib id="cr3" contrib-type="author"><name><surname>Shinkai</surname><given-names>Tetsu</given-names></name><xref ref-type="aff" rid="a1"><sup>1</sup></xref></contrib><contrib id="cr4" contrib-type="author"><name><surname>Tamura</surname><given-names>Tomohide</given-names></name><xref ref-type="aff" rid="a1"><sup>1</sup></xref></contrib><contrib id="cr5" contrib-type="author"><name><surname>Ohe</surname><given-names>Yuichiro</given-names></name><xref ref-type="aff" rid="a1"><sup>1</sup></xref></contrib><contrib id="cr6" contrib-type="author"><name><surname>Nisio</surname><given-names>Masato</given-names></name><xref ref-type="aff" rid="a1"><sup>1</sup></xref></contrib><contrib id="cr7" contrib-type="author"><name><surname>Kunikane</surname><given-names>Hiroshi</given-names></name><xref ref-type="aff" rid="a1"><sup>1</sup></xref></contrib><contrib id="cr8" contrib-type="author"><name><surname>Arioka</surname><given-names>Hitoshi</given-names></name><xref ref-type="aff" rid="a1"><sup>1</sup></xref></contrib><contrib id="cr9" contrib-type="author"><name><surname>Karato</surname><given-names>Atsuya</given-names></name><xref ref-type="aff" rid="a1"><sup>1</sup></xref></contrib><contrib id="cr10" contrib-type="author"><name><surname>Nakashima</surname><given-names>Hajime</given-names></name><xref ref-type="aff" rid="a1"><sup>1</sup></xref></contrib><contrib id="cr11" contrib-type="author"><name><surname>Sasaki</surname><given-names>Yasutsuna</given-names></name><xref ref-type="aff" rid="a3"><sup>3</sup></xref></contrib><contrib id="cr12" contrib-type="author"><name><surname>Tajima</surname><given-names>Kinuko</given-names></name><xref ref-type="aff" rid="a2"><sup>2</sup></xref></contrib><contrib id="cr13" contrib-type="author"><name><surname>Tada</surname><given-names>Noriko</given-names></name><xref ref-type="aff" rid="a1"><sup>1</sup></xref></contrib><contrib id="cr14" contrib-type="author"><name><surname>Saijo</surname><given-names>Nagahiro</given-names></name><xref ref-type="aff" rid="a4"><sup>4</sup></xref><xref ref-type="aff" rid="a1"><sup>1</sup></xref></contrib></contrib-group><aff id="a1"><label><sup>1</sup></label>Department of Internal Medicine and Thoracic Oncology</aff><aff id="a2"><label><sup>2</sup></label>Division of Drug Therapy and Siostatistics, National Cancer Center Central Hospital, 1&#x02010;1 Tsukiji 5&#x02010;chome, Chuo&#x02010;ku, Tokyo 104</aff><aff id="a3"><label><sup>3</sup></label><sup>3</sup>Division of Drug Therapy, National Cancer Center Hospital East, 6&#x02010;5&#x02010;1 Kashiwanoha, Kashiwa 277</aff><aff id="a4"><label><sup>4</sup></label><sup>8</sup> Division of Pharmacology, National Cancer Center Research Institute, 1&#x02010;1 Tsukiji 5&#x02010;chome, Chuo&#x02010;ku, Tokyo 104</aff><author-notes><corresp id="correspondenceTo"><label>*</label>To whom correspondence should be addressed (present address: Department of Respiratory Medicine, National Cancer Center Hospital East, 6&#x02010;5&#x02010;1 Kashiwanoha, Kashiwa 277).</corresp></author-notes><pub-date pub-type="ppub"><month>11</month><year>1994</year></pub-date><volume>85</volume><issue>11</issue><issue-id pub-id-type="doi">10.1111/cas.1994.85.issue-11</issue-id><fpage>1151</fpage><lpage>1158</lpage><history>
(Received April 22, 1994/Accepted August 26, 1994)</history><self-uri content-type="pdf" xlink:type="simple" xlink:href="file:CAS-85-1151.pdf"/><abstract><p>We carried out a randomized, single&#x02010;blind, cross&#x02010;over trial to compare the antiemetic effect, for both acute and delayed emesis, of granisetron plus dexamethasone (GRN+Dx) with that of high&#x02010;dose metoclopramide plus dexamethasone (HDMP + Dx). Fifty&#x02010;four patients with primary or metastatic lung cancer, given single&#x02010;dose cisplatin (&#x0003e; 80 mg/m<sup>2</sup>) chemotherapy more than twice, were enrolled in this study. They were treated with both HDMP+Dx and GRN+Dx in two consecutive chemotherapy courses. On day 1, patients experienced a mean of 2.5 (SD=4.3) and 0,1 (SD = 0.4) episodes of vomiting in the HDMP+Dx and the GRN + Dx groups, respectively (<italic>P</italic>=0.0008). Complete response rate on day 1 was 45 and 90% in the HDMP+Dx and the GRN+Dx groups, respectively (<italic>P</italic>= 0.0001). Patients treated with GRN+Dx had a tendency to suffer more episodes of vomiting than the HDMP+Dx group on days 2&#x02013;5, but it was not statistically significant. Twenty&#x02010;four patients (57%) preferred the GRN+Dx treatment and 14 patients (33%), HDMP + Dx. In the HDMP + Dx group, nine patients (21%) had an extrapyramidal reaction, and 5 patients (12%) had constipation that lasted for at least two days. In contrast, no patients had extrapyramidal reactions, and IS patients (43%) had constipation in the GRN+Dx group (<italic>P</italic> &#x0003c; 0.01). GRN+Dx was more effective than HDMP+Dx only in preventing the acute emesis induced by cisplatin. An effective treatment for delayed emesis is still needed.</p></abstract><kwd-group><kwd id="k1">Granisetron</kwd><kwd id="k2">Dexamethasone</kwd><kwd id="k3">Antiemetic</kwd><kwd id="k4">Cisplatin</kwd><kwd id="k5">Chemotherapy</kwd></kwd-group><counts><ref-count count="25"/><page-count count="8"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>November 1994</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:4.6.9 mode:remove_FC converted:04.11.2015</meta-value></custom-meta></custom-meta-group></article-meta></front><back><ref-list id="ss1"><title>REFERENCES</title><ref id="b1"><label>1</label><mixed-citation publication-type="journal" id="cit1">
)
<string-name><surname>Coates</surname>
,
<given-names>A.</given-names></string-name>
,
<string-name><surname>Abraham</surname>
,
<given-names>S.</given-names></string-name>
,
<string-name><surname>Kaye</surname>
,
<given-names>S. B.</given-names></string-name>
,
<string-name><surname>Sowerbutts</surname>
,
<given-names>T.</given-names></string-name>
,
<string-name><surname>Frewin</surname>
,
<given-names>C.</given-names></string-name>
,
<string-name><surname>Fox</surname>
,
<given-names>R. M.</given-names></string-name>
and
<string-name><surname>Tattersall</surname>
,
<given-names>M. H. N.</given-names></string-name><article-title>On the receiving end&#x02010;patient perception of the side&#x02010;effects of cancer chemotherapy</article-title>
.
<source>Eur. J. Cancer Clin, Oncol.</source>
,
<volume>19</volume>
,
<fpage>203</fpage>
&#x02013;
<lpage>208</lpage>
(
<year>1983</year>
).
<pub-id pub-id-type="pmid">6681766</pub-id></mixed-citation></ref><ref id="b2"><label>2</label><mixed-citation publication-type="journal" id="cit2">
)
<string-name><surname>Donovitz</surname>
,
<given-names>G. S.</given-names></string-name>
,
<string-name><surname>O'Quinn</surname>
,
<given-names>A. G.</given-names></string-name>
and
<string-name><surname>Smith</surname>
,
<given-names>M. L.</given-names></string-name><article-title>Antiemetic efficacy of high dose corticosteroids and droperidol in cisplatin&#x02010;induced emesis: a controlled trial with droperidol and metoclopramide</article-title>
.
<source>Gynecol Oncol.</source>
,
<volume>18</volume>
,
<fpage>320</fpage>
&#x02013;
<lpage>325</lpage>
(
<year>1984</year>
).
<pub-id pub-id-type="pmid">6540222</pub-id></mixed-citation></ref><ref id="b3"><label>3</label><mixed-citation publication-type="journal" id="cit3">
)
<string-name><surname>Hoagland</surname>
,
<given-names>A. C.</given-names></string-name>
,
<string-name><surname>Bennett</surname>
,
<given-names>J. M.</given-names></string-name>
,
<string-name><surname>Moorrow</surname>
,
<given-names>G. R.</given-names></string-name>
and
<string-name><surname>Carnike</surname>
,
<given-names>C. L. M.</given-names></string-name><article-title>Oncologist's views of cancer patient non&#x02010;compliance</article-title>
.
<source>Am. J. Clin. Oncol.</source>
,
<volume>6</volume>
,
<fpage>239</fpage>
&#x02013;
<lpage>244</lpage>
(
<year>1983</year>
).
<pub-id pub-id-type="pmid">6829498</pub-id></mixed-citation></ref><ref id="b4"><label>4</label><mixed-citation publication-type="journal" id="cit4">
)
<string-name><surname>Shinkai</surname>
,
<given-names>T.</given-names></string-name>
,
<string-name><surname>Saijo</surname>
,
<given-names>N.</given-names></string-name>
,
<string-name><surname>Eguchi</surname>
,
<given-names>K.</given-names></string-name>
,
<string-name><surname>Sasaki</surname>
,
<given-names>Y.</given-names></string-name>
,
<string-name><surname>Tamura</surname>
,
<given-names>T.</given-names></string-name>
,
<string-name><surname>Tominaga</surname>
,
<given-names>K.</given-names></string-name>
,
<string-name><surname>Sakurai</surname>
,
<given-names>M.</given-names></string-name>
,
<string-name><surname>Sano</surname>
,
<given-names>T.</given-names></string-name>
,
<string-name><surname>Taito</surname>
,
<given-names>H.</given-names></string-name>
,
<string-name><surname>Takahashi</surname>
,
<given-names>H.</given-names></string-name>
,
<string-name><surname>Nakano</surname>
,
<given-names>H.</given-names></string-name>
,
<string-name><surname>Nakagawa</surname>
,
<given-names>K.</given-names></string-name>
and
<string-name><surname>Suernasu</surname>
,
<given-names>K.</given-names></string-name><article-title>Antiemetic efficacy of high dose intravenous metoclopramide and dexamethasone in patients receiving cisplatinbases chemotherapy: a randomized controlled trial</article-title>
.
<source>Jpn. J. Clin. Oncol.</source>
,
<volume>16</volume>
,
<fpage>279</fpage>
&#x02013;
<lpage>287</lpage>
(
<year>1986</year>
).
<pub-id pub-id-type="pmid">3534348</pub-id></mixed-citation></ref><ref id="b5"><label>5</label><mixed-citation publication-type="journal" id="cit5">
)
<string-name><surname>Miner</surname>
,
<given-names>W. D.</given-names></string-name>
,
<string-name><surname>Sanger</surname>
,
<given-names>G. J.</given-names></string-name>
and
<string-name><surname>Turner</surname>
,
<given-names>D. H.</given-names></string-name><article-title>Evidence that 5&#x02010;hydroxytryptamine3 receptors mediate cytotoxic drug and radiation&#x02010;induced emesis</article-title>
.
<source>Br. J. Cancer</source>
,
<volume>56</volume>
,
<fpage>159</fpage>
&#x02013;
<lpage>162</lpage>
(
<year>1987</year>
).
<pub-id pub-id-type="pmid">3311109</pub-id></mixed-citation></ref><ref id="b6"><label>6</label><mixed-citation publication-type="journal" id="cit6">
)
<string-name><surname>Andrews</surname>
,
<given-names>P. L. R.</given-names></string-name>
and
<string-name><surname>Hawthorn</surname>
,
<given-names>J.</given-names></string-name><article-title>The neurophysiology of vomiting</article-title>
.
<source>Baillieres Clin. Gastroenterol.</source>
,
<volume>2</volume>
,
<fpage>141</fpage>
&#x02013;
<lpage>168</lpage>
(
<year>1988</year>
).
<pub-id pub-id-type="pmid">3289638</pub-id></mixed-citation></ref><ref id="b7"><label>7</label><mixed-citation publication-type="journal" id="cit7">
)
<string-name><surname>Humphrey</surname>
,
<given-names>P. P. A.</given-names></string-name><article-title>Peripheral 5&#x02010;hydroxytryptamine receptors and their classification</article-title>
.
<source>Neuropathy</source>
,
<volume>23</volume>
,
<fpage>1503</fpage>
&#x02013;
<lpage>1505</lpage>
(
<year>1984</year>
).
</mixed-citation></ref><ref id="b8"><label>8</label><mixed-citation publication-type="journal" id="cit8">
)
<string-name><surname>Kilpatrick</surname>
,
<given-names>G. L.</given-names></string-name>
,
<string-name><surname>Jones</surname>
,
<given-names>B. J.</given-names></string-name>
and
<string-name><surname>Tyers</surname>
,
<given-names>M. B.</given-names></string-name><article-title>Identification and distribution of 5HT<sub>3</sub> receptors in rat brain using radiological binding</article-title>
.
<source>Nature</source>
,
<volume>330</volume>
,
<fpage>746</fpage>
&#x02013;
<lpage>748</lpage>
(
<year>1987</year>
).
<pub-id pub-id-type="pmid">3696238</pub-id></mixed-citation></ref><ref id="b9"><label>9</label><mixed-citation publication-type="journal" id="cit9">
)
<string-name><surname>Khojasteh</surname>
,
<given-names>A.</given-names></string-name>
,
<string-name><surname>Sartiano</surname>
,
<given-names>G.</given-names></string-name>
,
<string-name><surname>Tapazoglou</surname>
,
<given-names>E.</given-names></string-name>
,
<string-name><surname>Lester</surname>
,
<given-names>E.</given-names></string-name>
,
<string-name><surname>Gandara</surname>
,
<given-names>D.</given-names></string-name>
,
<string-name><surname>Bernard</surname>
,
<given-names>S.</given-names></string-name>
and
<string-name><surname>Finn</surname>
,
<given-names>A.</given-names></string-name><article-title>Ondansetron for the prevention of emesis induced by high dose cisplatin</article-title>
.
<source>Cancer</source>
,
<volume>66</volume>
,
<fpage>1101</fpage>
&#x02013;
<lpage>1105</lpage>
(
<year>1990</year>
).
<pub-id pub-id-type="pmid">2144788</pub-id></mixed-citation></ref><ref id="b10"><label>10</label><mixed-citation publication-type="journal" id="cit10">
)
<string-name><surname>Bonneterre</surname>
,
<given-names>J.</given-names></string-name>
,
<string-name><surname>Chevallier</surname>
,
<given-names>B.</given-names></string-name>
,
<string-name><surname>Metz</surname>
,
<given-names>R.</given-names></string-name>
,
<string-name><surname>Fargeot</surname>
,
<given-names>P.</given-names></string-name>
,
<string-name><surname>Pujade&#x02010;Lauraine</surname>
,
<given-names>E.</given-names></string-name>
,
<string-name><surname>Spielmann</surname>
,
<given-names>M.</given-names></string-name>
,
<string-name><surname>Tubiana&#x02010;Hulin</surname>
,
<given-names>M.</given-names></string-name>
,
<string-name><surname>Paes</surname>
,
<given-names>D.</given-names></string-name>
and
<string-name><surname>Bons</surname>
,
<given-names>J.</given-names></string-name><article-title>A randomized double&#x02010;blind comparison of ondansetron and metoclopramide in the prophylaxis of emesis induced by cyclophosphamide, fluorouracil, and doxorubicin or epirubicin chemotherapy</article-title>
.
<source>J. clin. Oncol.</source>
,
<volume>8</volume>
,
<fpage>1063</fpage>
&#x02013;
<lpage>1069</lpage>
(
<year>1990</year>
).
<pub-id pub-id-type="pmid">2140854</pub-id></mixed-citation></ref><ref id="b11"><label>11</label><mixed-citation publication-type="journal" id="cit11">
)
<string-name><surname>Hainsworth</surname>
,
<given-names>J.</given-names></string-name>
,
<string-name><surname>Harvey</surname>
,
<given-names>W.</given-names></string-name>
,
<string-name><surname>Pendergrass</surname>
,
<given-names>K.</given-names></string-name>
,
<string-name><surname>Kasimis</surname>
,
<given-names>B.</given-names></string-name>
,
<string-name><surname>Oblon</surname>
,
<given-names>D.</given-names></string-name>
,
<string-name><surname>Monaghan</surname>
,
<given-names>G.</given-names></string-name>
,
<string-name><surname>Gandara</surname>
,
<given-names>D.</given-names></string-name>
,
<string-name><surname>Hesketh</surname>
,
<given-names>P.</given-names></string-name>
,
<string-name><surname>Khojasteh</surname>
,
<given-names>A.</given-names></string-name>
,
<string-name><surname>Barker</surname>
,
<given-names>G.</given-names></string-name>
,
<string-name><surname>York</surname>
,
<given-names>M.</given-names></string-name>
,
<string-name><surname>Siddiqui</surname>
,
<given-names>T.</given-names></string-name>
and
<string-name><surname>Finn</surname>
,
<given-names>A.</given-names></string-name><article-title>A single blind comparison of intravenous ondansetron, a selective serotonin antagonist, with intravenous metoclopramide in the prevention of nausea and vomiting associated with high dose cisplatin chemotherapy</article-title>
.
<source>J. Clin. Oncol.</source>
,
<volume>9</volume>
,
<fpage>721</fpage>
&#x02013;
<lpage>728</lpage>
(
<year>1991</year>
).
<pub-id pub-id-type="pmid">1826739</pub-id></mixed-citation></ref><ref id="b12"><label>12</label><mixed-citation publication-type="journal" id="cit12">
)
<string-name><surname>Roila</surname>
,
<given-names>R.</given-names></string-name>
,
<string-name><surname>Tonato</surname>
,
<given-names>M.</given-names></string-name>
,
<string-name><surname>Cognetti</surname>
,
<given-names>F.</given-names></string-name>
,
<string-name><surname>Cortesi</surname>
,
<given-names>E.</given-names></string-name>
,
<string-name><surname>Favalli</surname>
,
<given-names>G.</given-names></string-name>
,
<string-name><surname>Marangolo</surname>
,
<given-names>M.</given-names></string-name>
,
<string-name><surname>Amadori</surname>
,
<given-names>D.</given-names></string-name>
,
<string-name><surname>Bella</surname>
,
<given-names>M. A.</given-names></string-name>
,
<string-name><surname>Gramazio</surname>
,
<given-names>V.</given-names></string-name>
,
<string-name><surname>Donati</surname>
,
<given-names>D.</given-names></string-name>
,
<string-name><surname>Ballatori</surname>
,
<given-names>E.</given-names></string-name>
and
<string-name><surname>Favero</surname>
,
<given-names>A. D.</given-names></string-name><article-title>Prevention of cisplatin&#x02010;induced emesis: a double&#x02010;blind multicenter randomized crossover study comparing ondansetron and ondansetron plus dexamethasone</article-title>
.
<source>J. Clin. Oncol.</source>
,
<volume>9</volume>
,
<fpage>675</fpage>
&#x02013;
<lpage>678</lpage>
(
<year>1991</year>
).
<pub-id pub-id-type="pmid">1829757</pub-id></mixed-citation></ref><ref id="b13"><label>13</label><mixed-citation publication-type="journal" id="cit13">
)
<string-name><surname>Chevallier</surname>
,
<given-names>B.</given-names></string-name><article-title>Efficacy and safety of granisetron compared with high dose metoclopramide plus dexamethasone in patients receiving high dose cisplatin in a single&#x02010;blind study</article-title>
.
<source>Eur. J. Cancer</source>
,
<volume>26</volume>
,
<fpage>S33</fpage>
&#x02013;
<lpage>S36</lpage>
(
<year>1990</year>
).
<pub-id pub-id-type="pmid">2169784</pub-id></mixed-citation></ref><ref id="b14"><label>14</label><mixed-citation publication-type="journal" id="cit14">
)
<string-name><surname>Warr</surname>
,
<given-names>D.</given-names></string-name>
,
<string-name><surname>Willan</surname>
,
<given-names>A.</given-names></string-name>
,
<string-name><surname>Fine</surname>
,
<given-names>S.</given-names></string-name>
,
<string-name><surname>Wilson</surname>
,
<given-names>K.</given-names></string-name>
,
<string-name><surname>Davis</surname>
,
<given-names>A.</given-names></string-name>
,
<string-name><surname>Erlichman</surname>
,
<given-names>C.</given-names></string-name>
,
<string-name><surname>Rusthoven</surname>
,
<given-names>J.</given-names></string-name>
,
<string-name><surname>Lofters</surname>
,
<given-names>W.</given-names></string-name>
,
<string-name><surname>Osoba</surname>
,
<given-names>D.</given-names></string-name>
,
<string-name><surname>Laberge</surname>
,
<given-names>F.</given-names></string-name>
,
<string-name><surname>Latreille</surname>
,
<given-names>J.</given-names></string-name>
and
<string-name><surname>Pater</surname>
,
<given-names>J.</given-names></string-name><article-title>Superiority of granisetron to dexamethasone plus prochlorperazine in the prevention of chemotherapy&#x02010;induced emesis</article-title>
.
<source>J. Natl. Cancer Inst.</source>
,
<volume>83</volume>
,
<fpage>1169</fpage>
&#x02013;
<lpage>1173</lpage>
(
<year>1991</year>
).
<pub-id pub-id-type="pmid">1653363</pub-id></mixed-citation></ref><ref id="b15"><label>15</label><mixed-citation publication-type="journal" id="cit15">
)
<string-name><surname>Marty</surname>
,
<given-names>M.</given-names></string-name><article-title>A comparative study of the use of granisetron, a selective 5&#x02010;HT<sub>3</sub> antagonist, versus a standard antiemetic regimen of chlorpromazine plus dexamethasone in the treatment of cytostatic&#x02010;induced emesis</article-title>
.
<source>Eur. J. Cancer</source>
,
<volume>26</volume>
(
<issue>Suppl.</issue><bold>1</bold>
),
<fpage>S28</fpage>
&#x02013;
<lpage>S32</lpage>
(
<year>1990</year>
).
<pub-id pub-id-type="pmid">2169783</pub-id></mixed-citation></ref><ref id="b16"><label>16</label><mixed-citation publication-type="journal" id="cit16">
)
<string-name><surname>Bremer</surname>
,
<given-names>K.</given-names></string-name><article-title>A single&#x02010;blind study of the efficacy and safety of intravenous granisetron compared with alizapride plus dexamethasone in the prophylaxis and control of emesis in patients receiving 5&#x02010;day cytostatic therapy</article-title>
.
<source>Eur. J. Cancer</source>
,
<volume>28A</volume>
,
<fpage>1018</fpage>
&#x02013;
<lpage>1022</lpage>
(
<year>1992</year>
).
<pub-id pub-id-type="pmid">1320907</pub-id></mixed-citation></ref><ref id="b17"><label>17</label><mixed-citation publication-type="journal" id="cit17">
)
<string-name><surname>Soukop</surname>
,
<given-names>M.</given-names></string-name><article-title>A comparison of two dose levels of granisetron in patients receiving high dose cisplatin</article-title>
.
<source>Eur. J. Cancer</source>
,
<volume>26</volume>
,
<fpage>S15</fpage>
&#x02013;
<lpage>S19</lpage>
(
<year>1990</year>
).
<pub-id pub-id-type="pmid">2169779</pub-id></mixed-citation></ref><ref id="b18"><label>18</label><mixed-citation publication-type="journal" id="cit18">
)
<string-name><surname>Smith</surname>
,
<given-names>I. E.</given-names></string-name><article-title>A comparison of two dose levels of granisetron in patients receiving moderately emetogenic cytostatic chemotherapy</article-title>
.
<source>Eur. J. Cancer</source>
,
<volume>26</volume>
,
<fpage>S19</fpage>
&#x02013;
<lpage>S23</lpage>
(
<year>1990</year>
).
<pub-id pub-id-type="pmid">2169780</pub-id></mixed-citation></ref><ref id="b19"><label>19</label><mixed-citation publication-type="journal" id="cit19">
)
<string-name><surname>Warr</surname>
,
<given-names>D.</given-names></string-name>
,
<string-name><surname>Wilan</surname>
,
<given-names>A.</given-names></string-name>
,
<string-name><surname>Venner</surname>
,
<given-names>P.</given-names></string-name>
,
<string-name><surname>Pater</surname>
,
<given-names>J.</given-names></string-name>
,
<string-name><surname>Kaiser</surname>
,
<given-names>L.</given-names></string-name>
,
<string-name><surname>Laberge</surname>
,
<given-names>F.</given-names></string-name>
,
<string-name><surname>Latreille</surname>
,
<given-names>J.</given-names></string-name>
,
<string-name><surname>Stewart</surname>
,
<given-names>D.</given-names></string-name>
,
<string-name><surname>O'Connel</surname>
,
<given-names>G.</given-names></string-name>
,
<string-name><surname>Osoba</surname>
,
<given-names>D.</given-names></string-name>
,
<string-name><surname>Wilson</surname>
,
<given-names>K.</given-names></string-name>
,
<string-name><surname>Davis</surname>
,
<given-names>A.</given-names></string-name>
and
<string-name><surname>Johnston</surname>
,
<given-names>D.</given-names></string-name><article-title>A randomized double&#x02010;blind comparison of granisetron with high dose metoclopramide, dexamethasone and diphenhydramine for cisplatin&#x02010;induced emesis</article-title>
.
<source>Eur. J. Cancer</source>
,
<volume>29</volume>
,
<fpage>33</fpage>
&#x02013;
<lpage>36</lpage>
(
<year>1993</year>
).
</mixed-citation></ref><ref id="b20"><label>20</label><mixed-citation publication-type="journal" id="cit20">
)
<article-title>Italian Group for Antiemetic Research. Ondansetron + dexamethasone vs metoclopramide + dexamethasone + diphenhydramine in prevention of cisplatin&#x02010;induced emesis</article-title>
.
<source>Lancet</source>
,
<volume>340</volume>
,
<fpage>96</fpage>
&#x02013;
<lpage>99</lpage>
(
<year>1992</year>
).
<pub-id pub-id-type="pmid">1352024</pub-id></mixed-citation></ref><ref id="b21"><label>21</label><mixed-citation publication-type="journal" id="cit21">
)
<string-name><surname>Jones</surname>
,
<given-names>A. L.</given-names></string-name>
,
<string-name><surname>Hill</surname>
,
<given-names>A. S.</given-names></string-name>
,
<string-name><surname>Soukop</surname>
,
<given-names>M.</given-names></string-name>
,
<string-name><surname>Hutcheon</surname>
,
<given-names>A. W.</given-names></string-name>
,
<string-name><surname>Cassidy</surname>
,
<given-names>J.</given-names></string-name>
,
<string-name><surname>Kaye</surname>
,
<given-names>S. B.</given-names></string-name>
,
<string-name><surname>Sikora</surname>
,
<given-names>K.</given-names></string-name>
,
<string-name><surname>Carney</surname>
,
<given-names>D. N.</given-names></string-name>
and
<string-name><surname>Cunningham</surname>
,
<given-names>D.</given-names></string-name><article-title>Comparison of dexamethasone and ondansetron in the prophylaxis of emesis induced by moderately emetogenic chemotherapy</article-title>
.
<source>Lancet</source>
,
<volume>338</volume>
,
<fpage>483</fpage>
&#x02013;
<lpage>487</lpage>
(
<year>1991</year>
).
<pub-id pub-id-type="pmid">1678453</pub-id></mixed-citation></ref><ref id="b22"><label>22</label><mixed-citation publication-type="journal" id="cit22">
)
<string-name><surname>Moreno</surname>
,
<given-names>L.</given-names></string-name>
,
<string-name><surname>Resell</surname>
,
<given-names>R.</given-names></string-name>
,
<string-name><surname>Abad</surname>
,
<given-names>A.</given-names></string-name>
,
<string-name><surname>Barnadas</surname>
,
<given-names>A.</given-names></string-name>
,
<string-name><surname>Carles</surname>
,
<given-names>J.</given-names></string-name>
,
<string-name><surname>Ribelles</surname>
,
<given-names>N.</given-names></string-name>
,
<string-name><surname>Solano</surname>
,
<given-names>V.</given-names></string-name>
and
<string-name><surname>Font</surname>
,
<given-names>A.</given-names></string-name><article-title>Comparison of three protracted antiemetic regimens for the control of delayed emesis in cisplatin&#x02010;treated patients</article-title>
.
<source>Eur. J. Cancer</source>
,
<volume>28</volume>
,
<fpage>1344</fpage>
&#x02013;
<lpage>1347</lpage>
(
<year>1992</year>
).
</mixed-citation></ref><ref id="b23"><label>23</label><mixed-citation publication-type="journal" id="cit23">
)
<string-name><surname>Seynaeve</surname>
,
<given-names>C.</given-names></string-name>
,
<string-name><surname>Schuller</surname>
,
<given-names>J.</given-names></string-name>
,
<string-name><surname>Buser</surname>
,
<given-names>K.</given-names></string-name>
,
<string-name><surname>Porteder</surname>
,
<given-names>H.</given-names></string-name>
,
<string-name><surname>Belle</surname>
,
<given-names>S. V.</given-names></string-name>
,
<string-name><surname>Sevelda</surname>
,
<given-names>P.</given-names></string-name>
,
<string-name><surname>Christmann</surname>
,
<given-names>D.</given-names></string-name>
,
<string-name><surname>Schmidt</surname>
,
<given-names>M.</given-names></string-name>
,
<string-name><surname>Kitchener</surname>
,
<given-names>H.</given-names></string-name>
,
<string-name><surname>Paes</surname>
,
<given-names>D.</given-names></string-name>
and
<string-name><surname>de Mulder</surname>
,
<given-names>P. H. M.</given-names></string-name><article-title>Comparison of the antiemetic efficacy of different doses of ondansetron, given as either a continuous infusion or a single intravenous dose, in acute cisplatin&#x02010;induced emesis. A multicentre, double&#x02010;blind, randomised, parallel group study</article-title>
.
<source>Br. J. Cancer</source>
,
<volume>66</volume>
,
<fpage>192</fpage>
&#x02013;
<lpage>197</lpage>
(
<year>1992</year>
).
<pub-id pub-id-type="pmid">1386245</pub-id></mixed-citation></ref><ref id="b24"><label>24</label><mixed-citation publication-type="journal" id="cit24">
)
<string-name><surname>Kris</surname>
,
<given-names>M. G.</given-names></string-name>
,
<string-name><surname>Gralla</surname>
,
<given-names>R. J.</given-names></string-name>
,
<string-name><surname>Clark</surname>
,
<given-names>R. A.</given-names></string-name><string-name><surname>Tyson</surname>
,
<given-names>L. B.</given-names></string-name>
,
<string-name><surname>O'Connell</surname>
,
<given-names>J. P.</given-names></string-name>
,
<string-name><surname>Wertheim</surname>
,
<given-names>M. S.</given-names></string-name>
and
<string-name><surname>Kelsen</surname>
,
<given-names>D. P.</given-names></string-name><article-title>Incidence, course, and severity of delayed nausea and vomiting following the administration of high&#x02010;dose cisplatin</article-title>
.
<source>J. Clin. Oncol.</source>
,
<volume>3</volume>
,
<fpage>1379</fpage>
&#x02013;
<lpage>1384</lpage>
(
<year>1985</year>
).
<pub-id pub-id-type="pmid">4045527</pub-id></mixed-citation></ref><ref id="b25"><label>25</label><mixed-citation publication-type="journal" id="cit25">
)
<string-name><surname>Kamanabrou</surname>
,
<given-names>D.</given-names></string-name><article-title>Intravenous granisetron establishing the optimal dose</article-title>
.
<source>Eur. J. Cancer</source>
,
<volume>28A</volume>
, (
<issue>Suppl.</issue>
),
<fpage>S6</fpage>
&#x02013;
<lpage>Sll</lpage>
(
<year>1992</year>
).
<pub-id pub-id-type="pmid">1320919</pub-id></mixed-citation></ref></ref-list></back></article>